当社の製品について質問がありますか？ 早急に元に戻します
CPhI China
CPhI Worldwide
CPhI Korea
CPhI North America
DCAT Week
CPhI Japan Connect
White Paper: Redyx: Remdesivir formulation developed at Dr. Reddy’s under the license from Gilead
The winner of the Best Indian Company in the US - Manufacturing Sector for the year 2021
Sugammadex Sodium API – CADIFA Approval by ANVISA
ANVISA Certification of GMP Pharmaceutical Ingredients for 61 of Dr Reddy’s APIs
Whitepaper : Dr.Reddy's 2 DG- A promising treatment in hospitalized COVID-19 patients
Techsheet: Dr.Reddy's Lenvatinib API offerings
Bempedoic acid - a near term launch opportunity for generic pharma manufacturers
Managing the Product Life Cycle: Naproxen API and formulations
ROXADUSTAT - a multipronged development strategy
Challenges and Opportunities of Green Chemistry in the Pharmaceutical Industry
